IL98463A - Synergistic anti-malarial preparations containing Neplomatol - Google Patents

Synergistic anti-malarial preparations containing Neplomatol

Info

Publication number
IL98463A
IL98463A IL9846391A IL9846391A IL98463A IL 98463 A IL98463 A IL 98463A IL 9846391 A IL9846391 A IL 9846391A IL 9846391 A IL9846391 A IL 9846391A IL 98463 A IL98463 A IL 98463A
Authority
IL
Israel
Prior art keywords
benflumetol
compound
formula
effective amount
artemether
Prior art date
Application number
IL9846391A
Other languages
English (en)
Hebrew (he)
Other versions
IL98463A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25742651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL98463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL98463A0 publication Critical patent/IL98463A0/xx
Publication of IL98463A publication Critical patent/IL98463A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL9846391A 1990-08-08 1991-06-12 Synergistic anti-malarial preparations containing Neplomatol IL98463A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90106722A CN1058717A (zh) 1990-08-08 1990-08-08 抗疟新药—复方蒿甲醚及其制备方法
CN91102575A CN1085527C (zh) 1990-08-08 1991-04-24 增效复方抗疟药本芴醇的制备方法

Publications (2)

Publication Number Publication Date
IL98463A0 IL98463A0 (en) 1992-07-15
IL98463A true IL98463A (en) 1995-10-31

Family

ID=25742651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9846391A IL98463A (en) 1990-08-08 1991-06-12 Synergistic anti-malarial preparations containing Neplomatol

Country Status (27)

Country Link
US (1) US5677331A (fr)
EP (1) EP0500823B1 (fr)
JP (1) JP2562857B2 (fr)
KR (1) KR100221689B1 (fr)
CN (2) CN1058717A (fr)
AP (1) AP231A (fr)
AT (1) ATE135209T1 (fr)
AU (1) AU642747B2 (fr)
CA (1) CA2065285C (fr)
DE (2) DE69117922T2 (fr)
DK (1) DK0500823T3 (fr)
EG (1) EG19905A (fr)
ES (1) ES2084168T3 (fr)
FI (1) FI921491A0 (fr)
GR (1) GR3019313T3 (fr)
HK (1) HK1000312A1 (fr)
HU (1) HU227345B1 (fr)
IE (1) IE72095B1 (fr)
IL (1) IL98463A (fr)
LU (1) LU90844I2 (fr)
MA (1) MA22176A1 (fr)
NL (1) NL300048I2 (fr)
NZ (1) NZ238477A (fr)
PT (1) PT97945B (fr)
SA (1) SA91120263B1 (fr)
WO (1) WO1992002217A1 (fr)
ZA (1) ZA914490B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637594A (en) * 1991-04-11 1997-06-10 Ciba Geigy Corporation Antimalarial synergistic compositions containing benflumetol
HU220605B1 (hu) * 1992-02-07 2002-03-28 Novartis Ag. Eljárás benflumetol-tartalmú maláriaellenes szinergetikus gyógyászati készítmények előállítására
WO1995027964A1 (fr) * 1994-04-12 1995-10-19 Qualcomm Incorporated Procede et dispositif de transport de fret au moyen d'un systeme de navigation par satellite
US5657088A (en) * 1995-12-22 1997-08-12 Cirrus Logic, Inc. System and method for extracting caption teletext information from a video signal
US6136847A (en) * 1996-12-02 2000-10-24 Johns Hopkins University Water-soluble trioxanes as potent and safe antimalarial agents
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CO5040050A1 (es) 1998-06-25 2001-05-29 Novartis Ag Compuestos de 2-amino-1-(9-arilmetilidina-2,7-dicloro-9h- fluoren-4-ilo)-etanoles n-sustituidos, procedimientos para su obtencion y preparados farmaceuticos que los contienen .
IN191696B (fr) * 1999-02-12 2003-12-20 Council Scient Ind Res
EP1267864A1 (fr) * 2000-03-31 2003-01-02 Council Of Scientific & Industrial Research Formulation synergetique anti-paludique
US20040038933A1 (en) * 2000-10-20 2004-02-26 Yutaro Kaneko Pharmaceutical compositions, dose and method for treating malaria
US7842719B2 (en) * 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004075817A2 (fr) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Composition pharmaceutique pouvant etre mise en suspension
WO2005023304A2 (fr) * 2003-09-04 2005-03-17 Cipla Limited Compositions antipaludeennes et procede associe
US20110206636A1 (en) * 2003-09-16 2011-08-25 Kemin Foods, LLC Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
WO2007017646A2 (fr) * 2005-08-05 2007-02-15 Cipla Limited Composition antimalarienne
WO2007036947A1 (fr) * 2005-09-30 2007-04-05 Ipca Laboratories Limited Composition anti-paludéenne à libération retardée
US20090324715A1 (en) * 2006-06-26 2009-12-31 Sumit Madan High dose oral pharmaceutical compositions of artemether and lumefantrine
CN100463669C (zh) * 2006-08-31 2009-02-25 广州市医药工业研究所 复方蒿甲醚自乳化剂
WO2008098586A1 (fr) 2007-02-13 2008-08-21 Dafra Pharma N.V. Composition de support pharmaceutique et composition pharmaceutique
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
WO2010004573A1 (fr) * 2008-07-07 2010-01-14 Ipca Laboratories Limited Composition pharmaceutique synergiste antipaludique
PL2830433T3 (pl) * 2012-03-30 2019-05-31 Suedzucker Ag Udoskonalone proszki substancji do walcowania do nanoszenia na powierzchnię materiałów rdzenia gumy do żucia
CN103251584A (zh) * 2013-05-09 2013-08-21 西安力邦制药有限公司 注射用蒿甲醚/本芴醇复方脂肪乳的制备及其在疟疾治疗中的应用
WO2015140709A1 (fr) * 2014-03-19 2015-09-24 Novartis Ag Formes posologiques pharmaceutiques solides
CA3059327A1 (fr) 2017-04-24 2018-11-01 Novartis Ag Regime therapeutique de 2-amino-l-(2-(4-fluorophenyl)-3-(4-fluorophenylamino) -8,8-dimethyl-5,6-dihydroimidazo[1,2-a] pyrazin-7(8h)-yl)ethanone et leurs combinaisons
CN113599382B (zh) * 2021-08-20 2023-01-03 兰州大学 喹啉类衍生物在制备治疗糖尿病及其并发症药物中的应用
CN116747218B (zh) * 2023-08-21 2023-10-31 山东省中医药研究院 百秋李醇、百秋李醇复合抗疟组合物及制备抗疟原虫药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85100978A (zh) * 1985-04-01 1986-08-13 中医研究院中药研究所 还原青蒿素的生产工艺
CN85100781B (zh) * 1985-04-01 1988-07-06 广西壮族自治区桂林制药厂 抗疟药物青蒿酯的制备方法
CN87101346A (zh) * 1987-06-09 1988-03-09 山东省中医药研究所 青蒿素提取工艺
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
CN1029680C (zh) * 1988-11-10 1995-09-06 军事医学科学院微生物流行病研究所 抗疟新药苯芴醇的合成新工艺

Also Published As

Publication number Publication date
CN1085527C (zh) 2002-05-29
NL300048I2 (nl) 2002-03-01
DE69117922D1 (de) 1996-04-18
EP0500823A1 (fr) 1992-09-02
FI921491A (fi) 1992-04-03
IE72095B1 (en) 1997-03-12
AP9100275A0 (en) 1991-07-31
NL300048I1 (nl) 2001-10-01
CA2065285C (fr) 2000-05-09
LU90844I2 (fr) 2002-01-24
DE10199038I1 (de) 2001-11-22
SA91120263B1 (ar) 2004-08-31
DE10199038I2 (de) 2007-01-04
HUT61664A (en) 1993-03-01
HU227345B1 (en) 2011-04-28
IL98463A0 (en) 1992-07-15
GR3019313T3 (en) 1996-06-30
EP0500823B1 (fr) 1996-03-13
JP2562857B2 (ja) 1996-12-11
US5677331A (en) 1997-10-14
CA2065285A1 (fr) 1992-02-09
DE69117922T2 (de) 1996-09-05
FI921491A0 (fi) 1992-04-03
AU642747B2 (en) 1993-10-28
PT97945B (pt) 1998-11-30
ES2084168T3 (es) 1996-05-01
IE911989A1 (en) 1992-02-12
KR100221689B1 (ko) 1999-09-15
DK0500823T3 (da) 1996-04-01
JPH05501568A (ja) 1993-03-25
AP231A (en) 1993-01-31
MA22176A1 (fr) 1991-12-31
EG19905A (en) 1996-05-31
AU7954991A (en) 1992-03-02
CN1065993A (zh) 1992-11-11
ZA914490B (en) 1992-03-25
CN1058717A (zh) 1992-02-19
ATE135209T1 (de) 1996-03-15
KR920702217A (ko) 1992-09-03
HU9201528D0 (en) 1992-08-28
WO1992002217A1 (fr) 1992-02-20
PT97945A (pt) 1992-04-30
HK1000312A1 (en) 1998-02-27
NZ238477A (en) 1992-12-23

Similar Documents

Publication Publication Date Title
US5677331A (en) Antimalarial compositions
JPS62240619A (ja) 制癌剤
EP0750908A1 (fr) Remede contre les maladies infectieuses
EP0362810B1 (fr) Compositions contre la malaria et méthodes de traitement utilisant la quinidine, artémisinine ou leurs dérivés
AU614515B2 (en) A pharmaceutical combination for the prophylaxis and therapy of malaria
Sarciron et al. Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii.
EP0214101A2 (fr) Utilisation des fer(III) chelateurs du type desferrioxamine-B et desferriferrithiocine pour le traitement du paludisme
WO2005023304A2 (fr) Compositions antipaludeennes et procede associe
DE69936186T2 (de) Dihydroartemisinin-Formulierung zur Behandlung von verschiedenen Typen von Malaria
AU668376B2 (en) Antimalarial synergistic compositions containing benflumetol
EP0214933A2 (fr) Préparations à base de mélanges pour le traitement de la malaria
US5637594A (en) Antimalarial synergistic compositions containing benflumetol
EP0583439B1 (fr) Composition synergiques antipaludiques contenant du benflumetol
US3852454A (en) Treatment of rheumatoid arthritis
PL172590B1 (pl) Synergiczny srodek przeciwmalaryczny PL
OA10057A (fr) Compositions anti-paludeennes synergiques renfermant du benflumetol
JP2001503371A (ja) Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用
JPH01265025A (ja) Ｎ−置換−１−デオキシノジリマイシン誘導体を含有する癌細胞転移抑制剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired